Risk factors for and longitudinal course of male sexual dysfunction after robotic rectal cancer surgery.
Marie HanaokaHiroyasu KagawaAkio ShiomiHitoshi HinoShoichi ManabeYusuke YamaokaYusuke KinugasaPublished in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland (2023)
Neoadjuvant chemoradiotherapy was found to be a risk factor for erectile dysfunction after robot-assisted surgery for rectal cancer. Erectile function recovered postoperatively in patients undergoing lateral lymph node dissection; however, those receiving neoadjuvant chemoradiotherapy showed poor recovery, even at 12 months postoperatively.